Positron emission tomography imaging of vascular endothelial growth factor receptor expression with 61Cu-labeled lysine-tagged VEGF 121

Molecular Pharmaceutics

Volumn 9, Issue 12, 2012, Pages 3586-3594

  Zhang, Yin ^a   Hong, Hao ^b   Niu, Gang ^c   Valdovinos, Hector F ^a   Orbay, Hakan ^b   Nayak, Tapas R ^b   Chen, Xiaoyuan ^c   Barnhart, Todd E ^a   Cai, Weibo ^a,b,d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^d UNIVERSITY OF WISCONSIN   (United States)

Author keywords

61Cu; molecular imaging; positron emission tomography (PET); tumor angiogenesis; Vascular endothelial growth factor (VEGF); VEGF receptor (VEGFR)

Indexed keywords

ACETIC ACID DERIVATIVE; COPPER; LYSINE; VASCULOTROPIN 121; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BREAST CANCER; CONJUGATION; DISTRIBUTION VOLUME; DOSIMETRY; FEMALE; HISTOLOGY; IC 50; IN VITRO STUDY; ISOTOPE LABELING; LIVER; MOLECULAR IMAGING; MOUSE; NEOPLASM; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RADIATION DOSE; SIGNAL PROCESSING;

ANIMALS; BREAST NEOPLASMS; COPPER RADIOISOTOPES; FEMALE; HUMANS; LYSINE; MICE; MICE, INBRED BALB C; MOLECULAR IMAGING; NEOVASCULARIZATION, PATHOLOGIC; POSITRON-EMISSION TOMOGRAPHY; RADIOMETRY; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84870513207     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp3005269     Document Type: Article

References (48)

1. Ferrara, N. VEGF and the quest for tumour angiogenesis factors Nat. Rev. Cancer 2002, 2, 795-803 (Pubitemid 37328914)
2. Ferrara, N. Vascular endothelial growth factor: basic science and clinical progress Endocr. Rev. 2004, 25, 581-611 (Pubitemid 39099316)
3. Cai, W.; Chen, X. Multimodality imaging of vascular endothelial growth factor and vascular endothelial growth factor receptor expression Front. Biosci. 2007, 12, 4267-79
4. Backer, M. V.; Backer, J. M. Imaging key biomarkers of tumor angiogenesis Theranostics 2012, 2, 502-15
5. Sato, Y.; Kanno, S.; Oda, N.; Abe, M.; Ito, M.; Shitara, K.; Shibuya, M. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction Ann. N. Y. Acad. Sci. 2000, 902, 201-5 (discussion 205-7).
6. Underiner, T. L.; Ruggeri, B.; Gingrich, D. E. Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy Curr. Med. Chem. 2004, 11, 731-45 (Pubitemid 38380047)
7. Decaussin, M.; Sartelet, H.; Robert, C.; Moro, D.; Claraz, C.; Brambilla, C.; Brambilla, E. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival J. Pathol. 1999, 188, 369-77 (Pubitemid 29327434)
8. Ferrara, N.; Hillan, K. J.; Gerber, H. P.; Novotny, W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer Nat. Rev. Drug Discovery 2004, 3, 391-400 (Pubitemid 38618122)
9. Moroney, J. W.; Sood, A. K.; Coleman, R. L. Aflibercept in epithelial ovarian carcinoma Future Oncol. 2009, 5, 591-600
10. Spratlin, J. L.; Cohen, R. B.; Eadens, M.; Gore, L.; Camidge, D. R.; Diab, S.; Leong, S.; OBryant, C.; Chow, L. Q.; Serkova, N. J.; Meropol, N. J.; Lewis, N. L.; Chiorean, E. G.; Fox, F.; Youssoufian, H.; Rowinsky, E. K.; Eckhardt, S. G. Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2 J. Clin. Oncol. 2010, 28, 780-7
11. Ton, N. C.; Parker, G. J.; Jackson, A.; Mullamitha, S.; Buonaccorsi, G. A.; Roberts, C.; Watson, Y.; Davies, K.; Cheung, S.; Hope, L.; Power, F.; Lawrance, J.; Valle, J.; Saunders, M.; Felix, R.; Soranson, J. A.; Rolfe, L.; Zinkewich-Peotti, K.; Jayson, G. C. Phase I evaluation of CDP791, a PEGylated di-Fab conjugate that binds vascular endothelial growth factor receptor 2 Clin. Cancer Res. 2007, 13, 7113-8 (Pubitemid 350276896)
12. Fruehauf, J.; Lutzky, J.; McDermott, D.; Brown, C. K.; Meric, J. B.; Rosbrook, B.; Shalinsky, D. R.; Liau, K. F.; Niethammer, A. G.; Kim, S.; Rixe, O. Multicenter, phase II study of axitinib, a selective second-generation inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, in patients with metastatic melanoma Clin. Cancer Res. 2011, 17, 7462-9
13. Motzer, R. J.; Michaelson, M. D.; Redman, B. G.; Hudes, G. R.; Wilding, G.; Figlin, R. A.; Ginsberg, M. S.; Kim, S. T.; Baum, C. M.; DePrimo, S. E.; Li, J. Z.; Bello, C. L.; Theuer, C. P.; George, D. J.; Rini, B. I. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma J. Clin. Oncol. 2006, 24, 16-24 (Pubitemid 46630489)
14. Strumberg, D.; Richly, H.; Hilger, R. A.; Schleucher, N.; Korfee, S.; Tewes, M.; Faghih, M.; Brendel, E.; Voliotis, D.; Haase, C. G.; Schwartz, B.; Awada, A.; Voigtmann, R.; Scheulen, M. E.; Seeber, S. Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors J. Clin. Oncol. 2005, 23, 965-72 (Pubitemid 46202316)
15. Folkman, J. Angiogenesis: an organizing principle for drug discovery? Nat. Rev. Drug Discovery 2007, 6, 273-86 (Pubitemid 46505878)
16. Cai, W.; Hong, H. Peptoid and positron emission tomography: an appealing combination Am. J. Nucl. Med. Mol. Imaging 2011, 1, 76-79
17. 111In for imaging tumor angiogenesis J. Nucl. Med. 2005, 46, 1745-52 (Pubitemid 46211599)
18. Backer, M. V.; Levashova, Z.; Patel, V.; Jehning, B. T.; Claffey, K.; Blankenberg, F. G.; Backer, J. M. Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes Nat. Med. 2007, 13, 504-9 (Pubitemid 46559824)
19. 99mTc-HYNIC-VEGF Eur. J. Nucl. Med. Mol. Imaging 2006, 33, 841-8 (Pubitemid 43979693)
20. 165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma Q. J. Nucl. Med. Mol. Imaging 2004, 48, 198-206 (Pubitemid 39485387)
21. Cai, W.; Chen, K.; Mohamedali, K. A.; Cao, Q.; Gambhir, S. S.; Rosenblum, M. G.; Chen, X. PET of vascular endothelial growth factor receptor expression J. Nucl. Med. 2006, 47, 2048-56 (Pubitemid 47544993)
22. Wang, H.; Cai, W.; Chen, K.; Li, Z. B.; Kashefi, A.; He, L.; Chen, X. A new PET tracer specific for vascular endothelial growth factor receptor 2 Eur. J. Nucl. Med. Mol. Imaging 2007, 34, 2001-10 (Pubitemid 350212131)
23. 121/rGel J. Nucl. Med. 2007, 48, 445-54 (Pubitemid 47604931)
24. 68Ga]PET imaging of VEGF receptors in angiogenic vasculature Nucl. Med. Biol. 2010, 37, 405-12
25. Wang, H.; Gao, H.; Guo, N.; Niu, G.; Ma, Y.; Kiesewetter, D. O.; Chen, X. Site-Specific Labeling of scVEGF with Fluorine-18 for Positron Emission Tomography Imaging Theranostics 2012, 2, 607-617
26. 121 for near-infrared fluorescence imaging of tumor angiogenesis Mol. Pharmaceutics 2009, 6, 285-94
27. De Leon-Rodriguez, L. M.; Lubag, A.; Udugamasooriya, D. G.; Proneth, B.; Brekken, R. A.; Sun, X.; Kodadek, T.; Dean Sherry, A. MRI detection of VEGFR2 in vivo using a low molecular weight peptoid-(Gd)8-dendron for targeting J. Am. Chem. Soc. 2010, 132, 12829-31
28. Willmann, J. K.; Paulmurugan, R.; Chen, K.; Gheysens, O.; Rodriguez-Porcel, M.; Lutz, A. M.; Chen, I. Y.; Chen, X.; Gambhir, S. S. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice Radiology 2008, 246, 508-18
29. Korpanty, G.; Carbon, J. G.; Grayburn, P. A.; Fleming, J. B.; Brekken, R. A. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature Clin. Cancer Res. 2007, 13, 323-30 (Pubitemid 46121886)
30. Cai, W.; Chen, X. Multimodality molecular imaging of tumor angiogenesis J. Nucl. Med. 2008, 49 (Suppl. 2) 113S-28S (Pubitemid 351948040)
31. Hong, H.; Yang, Y.; Zhang, Y.; Engle, J. W.; Barnhart, T. E.; Nickles, R. J.; Leigh, B. R.; Cai, W. Positron emission tomography imaging of CD105 expression during tumor angiogenesis Eur. J. Nucl. Med. Mol. Imaging 2011, 38, 1335-43
32. Zhang, Y.; Hong, H.; Engle, J. W.; Yang, Y.; Barnhart, T. E.; Cai, W. Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab Am. J. Nucl. Med. Mol. Imaging 2012, 2, 1-13
33. Zhang, Y.; Hong, H.; Engle, J. W.; Yang, Y.; Theuer, C. P.; Barnhart, T. E.; Cai, W. Positron Emission Tomography and Optical Imaging of Tumor CD105 Expression with a Dual-Labeled Monoclonal Antibody Mol. Pharm. 2012, 9, 645-53
34. Hong, H.; Benink, H. A.; Zhang, Y.; Yang, Y.; Uyeda, H. T.; Engle, J. W.; Severin, G. W.; McDougall, M. G.; Barnhart, T. E.; Klaubert, D. H.; Nickles, R. J.; Fan, F.; Cai, W. HaloTag: a novel reporter gene for positron emission tomography Am. J. Transl. Res. 2011, 3, 392-403
35. Sgouros, G. Dosimetry of internal emitters J. Nucl. Med. 2005, 46 (Suppl. 1) 18S-27S (Pubitemid 47619015)
36. Keyt, B. A.; Nguyen, H. V.; Berleau, L. T.; Duarte, C. M.; Park, J.; Chen, H.; Ferrara, N. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis J. Biol. Chem. 1996, 271, 5638-46
37. 18F-FDG PET in sarcoma treatment response imaging Am. J. Nucl. Med. Mol. Imaging 2011, 1, 47-53
38. 11C-acetate Am. J. Nucl. Med. Mol. Imaging 2012, 2, 33-47
39. 18F-FDG PET/CT: timing for evaluation of response to therapy remains a clinical challenge Am. J. Nucl. Med. Mol. Imaging 2011, 1, 63-64
40. Nolting, D. D.; Nickels, M. L.; Guo, N.; Pham, W. Molecular imaging probe development: a chemistry perspective Am. J. Nucl. Med. Mol. Imaging 2012, 2, 273-306
41. Thorek, D. L. J.; Robertson, R.; Bacchus, W. A.; Hahn, J.; Rothberg, J.; Beattie, B. J.; Grimm, J. Cerenkov imaging-a new modality for molecular imaging Am. J. Nucl. Med. Mol. Imaging 2012, 2, 163-173
42. Zhang, L.; Chang, R. C.; Chu, L.; Mak, H. K. Current neuroimaging techniques in Alzheimers disease and applications in animal models Am. J. Nucl. Med. Mol. Imaging 2012, 2, 386-404
43. McCarthy, D. W.; Bass, L. A.; Cutler, P. D.; Shefer, R. E.; Klinkowstein, R. E.; Herrero, P.; Lewis, J. S.; Cutler, C. S.; Anderson, C. J.; Welch, M. J. High purity production and potential applications of copper-60 and copper-61 Nucl. Med. Biol. 1999, 26, 351-8 (Pubitemid 29254019)
44. 18F-based radiotracers Am. J. Nucl. Med. Mol. Imaging 2012, 2, 55-76
45. Cai, W.; Niu, G.; Chen, X. Imaging of integrins as biomarkers for tumor angiogenesis Curr. Pharm. Des. 2008, 14, 2943-73
46. 64Cu-labeled antibody Nucl. Med. Biol. 2011, 38, 29-38
47. 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA PLoS One 2011, 6, e28005
48. 64Cu- Complexing Bifunctional Chelators for Radioimmunoconjugation: Labeling Efficiency, Specific Activity, and in Vitro/in Vivo Stability Bioconjugate Chem. 2012, 23, 1029-1039